| EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection (NCT03266653) | New York Medical College | 2020-07-07 |
| Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) (NCT04197596) | New York Medical College | 2020-07-01 |
| Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) (NCT04354818) | Kirby Institute | 2020-05-11 |
| Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures (NCT04232085) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-02-12 |
| Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases (NCT03939533) | Octapharma | 2019-10-17 |
| Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency (NCT03492710) | Green Cross Corporation | 2019-04-30 |
| Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection (NCT03266627) | New York Medical College | 2018-11-01 |
| Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) (NCT03266640) | New York Medical College | 2018-11-01 |
| Primary Immunodeficiency in Kuwait (NCT03618147) | Kuwait Society for Allergy and Clinical Immunology | 2018-07-16 |
| The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease (NCT03211689) | Stockton University | 2017-06-27 |
| Immunological Characteristics of Patients With PID and IBD (NCT03148028) | Sheba Medical Center | 2017-05-15 |
| Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases (NCT03988426) | Octapharma | 2017-03-07 |
| Investigation of Dental Health in Children With Neutrophil Defects: A Clinical Study (NCT03069079) | Queen Mary University of London | 2016-12-01 |
| A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products (NCT03037359) | ADMA Biologics, Inc. | 2016-12-01 |
| Identification of New Inborn Errors of Immunity (NCT03414528) | University of Zurich | 2016-09-23 |
| Pathophysiology of Inborn Immunodeficiencies (NCT03422614) | University of Zurich | 2015-03-01 |
| Intensive Care Unit and Secondary and Primary Immune Deficiency (NCT02888535) | University Hospital, Caen | 2015-01-01 |
| Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant (NCT03301168) | Bellicum Pharmaceuticals | 2014-04-01 |
| Study of Octanorm Subcutaneous IG in Patients With PID (NCT01888484) | Octapharma | 2014-03-01 |
| Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD) (NCT01814800) | ADMA Biologics, Inc. | 2014-02-01 |
| Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI) (NCT01883921) | BriovaRx Infusion Services | 2013-06-01 |
| Octagam 5% Versus Comparator Post Marketing Trial (NCT01859754) | Octapharma | 2013-05-21 |
| TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID (NCT02327351) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2012-07-01 |
| Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) (NCT01458171) | CSL Behring | 2011-04-01 |
| Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency (NCT01131858) | Karolinska University Hospital | 2010-03-01 |